Ativos Alterar Data
AbbVie USD 147.68B 12.57B 2026-09
Align Technology USD 6.52B 103.03M 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Charles River Laboratories USD 7.45B 80.64M 2026-09
Coherus Biosciences USD 191.18M 74.84M 2026-06
Dentsply International USD 5.19B 14M 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Henry Schein USD 11.51B 129M 2026-09
Idexx Laboratories USD 3.71B 264.77M 2026-09
Illumina USD 6.81B 162M 2026-09
IQVIA Holdings USD 30.47B 593M 2026-09
J&J USD 197.42B 3.64B 2026-09
Laboratory Of America USD 18.92B 392.3M 2026-09
Merck USD 132.77B 2.97B 2026-09
Neogen USD 3.3B 42.8M 2026-06
Pacira USD 34.68B 33.44B 2026-09
Perrigo USD 7.48B 124.6M 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Phibro Animal Health USD 1.51B 13.48M 2026-09
Quest Diagnostics USD 17.22B 282M 2026-09
Sanofi EUR 130.29B 1.23B 2026-09
Sanofi EUR 129.06B 1.04B 2026-06
Zoetis USD 15.09B 11M 2026-09